Bivalirudin: A direct thrombin inhibitor
- 1 January 2002
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 24 (1) , 38-58
- https://doi.org/10.1016/s0149-2918(02)85004-4
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationNew England Journal of Medicine, 2001
- Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and SafetyChest, 2001
- Beyond Heparin and AspirinArchives of internal medicine (1960), 2000
- Unstable Angina PectorisNew England Journal of Medicine, 2000
- Heparin and Low-Molecular-Weight HeparinChest, 1998
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.Circulation, 1993
- Protection of factor Xa from neutralization by the heparin-antithrombin complex.Journal of Clinical Investigation, 1983